Patent details

EP1755596 Title: PROCESS FOR PREPARING ATAZANAVIR BISULFATE AND NOVEL FORMS

Basic Information

Publication number:
EP1755596
PCT Application Number:
PCT/US/2005/015333
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP057445371
PCT Publication Number:
WO/2005/108349
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROCESS FOR PREPARING ATAZANAVIR BISULFATE AND NOVEL FORMS
French Title of Invention:
PROCEDE POUR LA PREPARATION DE BISULFATE D'ATAZANAVIR ET DE NOUVELLES FORMES
German Title of Invention:
VERFAHREN ZUR HERSTELLUNG VON ATAZANAVIRBISULFAT UND NEUE FORMEN
SPC Number:

Dates

Filing date:
03/05/2005
Grant date:
12/08/2015
EP Publication Date:
12/08/2015
PCT Publication Date:
17/11/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2007
EP B1 Publication Date:
12/08/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/05/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/01/2019
 
 

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:
18/07/2015
To:
23/01/2019

Name:
Bristol-Myers Squibb Holdings Ireland
Address:
Hinterbergstrasse 16, 6312 Steinhausen, Switzerland (CH)

Agent

Name:
MARKS & CLERK LLP
From:
04/09/2015
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
DAVIDOVICH Martha
Address:
United States (US)

2

Name:
GOUGOUTAS Jack, Z.
Address:
United States (US)

3

Name:
KIM Soojin
Address:
United States (US)

4

Name:
SRIVASTAVA Sushil, K.
Address:
United States (US)

5

Name:
LOTZ Bruce, T.
Address:
United States (US)

6

Name:
MALLEY Mary, F.
Address:
United States (US)

Priority

1

Priority Number:
568043 P
Priority Date:
04/05/2004
Priority Country:
United States (US)

2

Priority Number:
607533 P
Priority Date:
07/09/2004
Priority Country:
United States (US)

3

Priority Number:
119558
Priority Date:
02/05/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 213/56;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20190000045A
Date Registered:
23/01/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/04/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/01/2019 Outgoing Correspondence 1
23/01/2019 Request For Change 6
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56